Stem cell assisted centrifugal fat transfer
- Conditions
- Facial agingSkin AgingAging
- Registration Number
- RPCEC00000362
- Lead Sponsor
- Hermanos Ameijeiras Surgical Clinical Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Patients between the ages of 30 and 59, without distinction of sex.
2. Patients with signs of facial aging.
3. Willingness to participate in the study, with prior written informed consent.
4. Compensated chronic diseases, if you suffer from them.
1. History of psychiatric disorders or coagulopathies.
2. Patients whose expectations cannot be achieved with the procedure.
3. Pregnant or lactating women.
4. Tendency to keloid.
5. Skin or systemic infection.
6. Patients who are on anticoagulant, antifibrinolytic or non-steroidal anti-inflammatory drugs (NSAIDs) or steroids.
7. History of having made facial lipotransfer or injected other substances as fillers in the face.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the final result: (Good, Fair, Bad). Measurement time: 12 months after the intervention.
- Secondary Outcome Measures
Name Time Method 1. Clinical evolution of furrows and wrinkles (Clinical response to treatment interpreted by doctor and patient, using the Global Aesthetic Improvement Scale (GAIS)] (Exceptional improvement. Total disappearance of wrinkles, Much improved. Marked partial response. Decrease in the number of wrinkles between 50 and 99%, Improved. Slight partial response. Decrease in the number of wrinkles less than 50%, No response. Same as at the beginning of treatment, Progression. Increased number or size of wrinkles )). Measurement time: 12 months after the intervention.<br>2. Satisfaction status: (Satisfied, Not satisfied). Measurement time: 12 months after the intervention. <br>3. Complications (Yes, No). Measurement time: 24 and 72 hours, 1 week and, 3, 6 and 12 months after the intervention.<br>4. Type of complications (Describe complications that appear). Measurement time: 24 and 72 hours, 1 week and, 3, 6 and 12 months after the intervention.